Reuters | Thursday December 1, 2022
Neuralink is expected to begin human trials in six months, Elon Musk said on Wednesday. The brain chip interface is running behind schedule, and is said to have repeatedly missed internal deadlines to gain US Food and Drug Administration (FDA) approval to start human trials. Over a year ago, Neuralink demonstrated its technology on a monkey with a ...
www.gadgets360.com